<?xml version="1.0" encoding="UTF-8"?><add><doc><field name="id">0001830</field><field name="title">TO SELL 100 MLN DLRS DEBENTURES</field><field name="place">ROSEMONT, ILL.</field><field name="date">March 6</field><field name="content">- LyphoMed Inc said it intends to file a registration statement with the Securities and Exchange Commission covering the sale of 70 mln dlrs principal amount of convertible subordinated debentures.     Concurrent with the debenture offering, LyphoMed said it plans to sell an additional 30 mln dlrs of debentures in Fujisawa Pharmaceutical Co Ltd, which currently owns about 30 pct of the company's common stock.     It said the offering will be made only by prospectus. </field></doc></add>